These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 25355140

  • 1. Balance of Treg versus T-effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol-betamethasone dipropionate ointment.
    Keijsers RR, Joosten I, Hendriks AG, Koenen HJ, van Erp PE, van de Kerkhof PC.
    Exp Dermatol; 2015 Jan; 24(1):65-7. PubMed ID: 25355140
    [Abstract] [Full Text] [Related]

  • 2. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis.
    Vissers WH, Berends M, Muys L, van Erp PE, de Jong EM, van de Kerkhof PC.
    Exp Dermatol; 2004 Feb; 13(2):106-12. PubMed ID: 15009104
    [Abstract] [Full Text] [Related]

  • 3. Pulsed dye laser versus treatment with calcipotriol/betamethasone dipropionate for localized refractory plaque psoriasis: effects on T-cell infiltration, epidermal proliferation and keratinization.
    Bovenschen HJ, Erceg A, Van Vlijmen-Willems I, Van De Kerkhof PC, Seyger MM.
    J Dermatolog Treat; 2007 Feb; 18(1):32-9. PubMed ID: 17365265
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of phototherapy, adalimumab and betamethasone-calcipotriol on effector and regulatory T cells in psoriasis.
    Kotb IS, Lewis BJ, Barker RN, Ormerod AD.
    Br J Dermatol; 2018 Jul; 179(1):127-135. PubMed ID: 29330859
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 6. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
    Kubin ME, Kokkonen N, Palatsi R, Hägg PM, Väyrynen JP, Glumoff V, Haapasaari KM, Hurskainen T, Tasanen K.
    Acta Derm Venereol; 2017 Apr 06; 97(4):449-455. PubMed ID: 27868150
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The DESIRE study--psoriasis patients' satisfaction with topical treatment using a fixed combination of calcipotriol and betamethasone dipropionate in daily clinical practice.
    Claréus BW, Houwing R, Sindrup JH, Wigchert S.
    Eur J Dermatol; 2009 Apr 06; 19(6):581-5. PubMed ID: 19726275
    [Abstract] [Full Text] [Related]

  • 14. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference.
    Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR.
    Cutis; 2014 Dec 06; 94(6):304-9. PubMed ID: 25566573
    [Abstract] [Full Text] [Related]

  • 15. Treatment of nail psoriasis with a two-compound formulation of calcipotriol plus betamethasone dipropionate ointment.
    Rigopoulos D, Gregoriou S, Daniel Iii CR, Belyayeva H, Larios G, Verra P, Stamou C, Kontochristopoulos G, Avgerinou G, Katsambas A.
    Dermatology; 2009 Dec 06; 218(4):338-41. PubMed ID: 19212110
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Clearing of psoriasis documented by laser Doppler perfusion imaging contrasts remaining elevation of dermal expression levels of CD31.
    Hendriks AG, van de Kerkhof PC, de Jonge CS, Lucas M, Steenbergen W, Seyger MM.
    Skin Res Technol; 2015 Aug 06; 21(3):340-5. PubMed ID: 25534374
    [Abstract] [Full Text] [Related]

  • 18. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
    Vissers WH, van Vlijmen I, van Erp PE, de Jong EM, van de Kerkhof PC.
    Br J Dermatol; 2008 Apr 06; 158(4):705-12. PubMed ID: 18284400
    [Abstract] [Full Text] [Related]

  • 19. Retrospective assessment of PASI 50 and PASI 75 attainment with a calcipotriol/betamethasone dipropionate ointment.
    Anstey AV, Kragballe K.
    Int J Dermatol; 2006 Aug 06; 45(8):970-5. PubMed ID: 16911387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.